Daily Supplements May Slow 'Dry' Form of Macular Degeneration
By Dennis Thompson HealthDay Reporter
MONDAY, July 22, 2024 -- Daily supplements can slow loss of vision related to late-stage “dry” age-related macular degeneration (AMD), a new study finds.
The rate of dry AMD progression into a key eye region slowed by about 55% over an average three years for late-stage patients who took a daily blend of antioxidants and minerals, researchers reported July 16 in the journal Ophthalmology.
Prior results have shown that supplements slow the progression from intermediate to late AMD, said lead researcher Dr. Tiarnan Keenan, a staff clinician with the National Eye Institute.
“Our analysis shows that taking … supplements can also slow disease progression in people with late dry AMD,” Keenan said in an institute news release.
The supplements include the antioxidants vitamin C, E, beta-carotene, lutein and zeaxanthin, along with the minerals zinc and copper.
Dry AMD is the most common form of macular degeneration, affecting nine out of 10 people with the eye condition, the Cleveland Clinic says.
Dry AMD occurs when small yellow deposits of fatty proteins called drusen start to develop along the light-sensing retina at the back of a person’s eye, researchers explained in background notes.
These deposits cause the loss of light-sensitive cells in the retina, a condition called “geographic atrophy” that slowly expands over time. As a result, people progressively lose their central vision.
The new study focused on the fovea, a small depression at the center of the retina that is responsible for sharp central vision.
Many people with dry AMD first develop geographic atrophy outside the fovea, and only lose their central vision when AMD encroaches into the fovea, researchers noted.
For the new study, researchers reviewed data on more than 1,200 participants in two clinical trials testing the effectiveness of supplements to slow AMD progression. The trials were funded by the federal government.
The analysis showed that for people whose dry AMD hadn’t affected the fovea, taking supplements could slow the progression of the eye disease to that crucial region.
“Our high acuity central vision is essential for tasks like reading and driving,” Keenan said. “Given that there are few therapeutic options for people with late-stage dry AMD to retain or restore their vision, antioxidant supplementation is a simple step that may slow central vision loss, even for those with late disease.”
Researchers plan to conduct a follow-up clinical trial to confirm these results, Keenan added.
Sources
- National Eye Institute, news release, July 16, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Why Treatments Can Fail Folks With 'Wet' Macular Degeneration -- and What Might Really Work
TUESDAY, Nov. 5, 2024 -- Current treatments sometimes fail to help people with “wet” age-related macular degeneration -- and researchers now think they know why. Wet...
Light Therapy Might Help Ease 'Dry' Form of Macular Degeneration
TUESDAY, Oct. 22, 2024 -- Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says. The therapy, called...
Stem Cell Therapy Might Repair Vision-Robbing Holes in Retinas
THURSDAY, Oct. 3, 2024 -- Japanese researchers have successfully used a transplant of human stem cells to close a hole in a key part of a monkey's retina. They say the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.